首页 > 最新文献

Joint Bone Spine最新文献

英文 中文
An inflammatory mass of periodontoid space resulting from calcium crystal deposition 由钙晶体沉积引起的牙周间隙的炎性肿块。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-10-06 DOI: 10.1016/j.jbspin.2025.105987
Sophie Pouplin, Mathilde Baril, Benjamin Hebant
{"title":"An inflammatory mass of periodontoid space resulting from calcium crystal deposition","authors":"Sophie Pouplin, Mathilde Baril, Benjamin Hebant","doi":"10.1016/j.jbspin.2025.105987","DOIUrl":"10.1016/j.jbspin.2025.105987","url":null,"abstract":"","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 1","pages":"Article 105987"},"PeriodicalIF":4.3,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology, outcomes, and expenditures of hospitalized patients with systemic sclerosis: Insights from the U.S. National Inpatient Sample 系统性硬化症住院患者的流行病学、结局和支出:来自2021年全国住院患者样本的见解
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-30 DOI: 10.1016/j.jbspin.2025.105985
Patompong Ungprasert , Paul T. Kroner

Objectives

The inpatient epidemiology, morbidity, mortality, and healthcare expenditures associated with systemic sclerosis (SSc) remain poorly characterized. This study utilizes a national inpatient database to provide a comprehensive assessment of these parameters.

Methods

We identified adult patients with SSc from the 2021 National Inpatient Sample (NIS) using ICD-10-CM codes. The NIS, the largest publicly available all-payer inpatient healthcare database in the U.S., represents data from over 4000 non-federal acute care hospitals. A matched comparator group without SSc was created to serve as comparators. Extracted data included demographics, primary admission diagnoses, length of stay (LOS), in-hospital mortality and morbidity, comorbidities, and healthcare expenditures. Multivariable analyses were adjusted for age, sex, race/ethnicity, Charlson Comorbidity Index, payer type, median income, and hospital characteristics.

Results

The inpatient prevalence of SSc was 86.7 per 100,000 admissions. The most common primary diagnoses among SSc hospitalizations were sepsis (22.7%), heart failure with hypertension (14.4%), and COVID-19 (11.5%). The cohort was predominantly female (84.2%) with a mean age of 63.5 years. Compared to non-SSc admissions, SSc hospitalizations were associated with significantly longer LOS (mean difference 0.7 days; 95% CI: 0.5–0.9) and greater healthcare costs, including an adjusted mean increase of $3277 in hospital costs (95% CI: $2051–$4504) and $11,801 in total charges (95% CI: $6485–$17,116). SSc was also associated with increased odds of in-hospital mortality (adjusted OR 1.42; 95% CI: 1.26–1.61), shock (aOR 1.30; 95% CI: 1.17–1.44), systemic inflammatory response syndrome (aOR 1.32; 95% CI: 1.01–1.74), and acute respiratory distress syndrome (aOR 1.45; 95% CI: 1.12–1.87). Multivariate analysis also revealed that patients with SSc had significantly higher odds of several comorbid conditions, including pulmonary hypertension, interstitial lung disease, osteoporosis, Sjögren's syndrome, and hypertension.

Conclusions

The inpatient prevalence of SSc exceeds its general population prevalence, indicating a high need for hospital-level care. Hospitalizations among patients with SSc are associated with worse clinical outcomes and significantly greater healthcare expenditures.
目的:与系统性硬化症(SSc)相关的住院流行病学、发病率、死亡率和医疗支出的特征仍然很差。本研究利用国家住院病人数据库提供这些参数的综合评估。方法:我们使用ICD-10-CM代码从2021年国家住院患者样本(NIS)中识别成年SSc患者。NIS是美国最大的可公开获得的全付款人住院医疗保健数据库,代表了来自4,000多家非联邦急症护理医院的数据。创建一个没有SSc的匹配比较组作为比较器。提取的数据包括人口统计、初次入院诊断、住院时间(LOS)、住院死亡率和发病率、合并症和医疗支出。多变量分析调整了年龄、性别、种族/民族、查尔森合并症指数、付款人类型、收入中位数和医院特征。结果:SSc的住院患病率为86.7 / 10万。SSc住院患者中最常见的主要诊断是败血症(22.7%)、心力衰竭合并高血压(14.4%)和COVID-19(11.5%)。该队列以女性为主(84.2%),平均年龄为63.5岁。与非SSc住院相比,SSc住院与更长的生存期(平均差0.7天;95% CI: 0.5-0.9)和更高的医疗保健费用相关,包括住院费用调整后平均增加3,277美元(95% CI: 2,051- 4,504美元)和总费用增加11,801美元(95% CI: 6,485- 17,116美元)。SSc还与住院死亡率(校正OR 1.42; 95% CI: 1.26-1.61)、休克(aOR 1.30; 95% CI: 1.17-1.44)、全身炎症反应综合征(aOR 1.32; 95% CI: 1.01-1.74)和急性呼吸窘迫综合征(aOR 1.45; 95% CI: 1.12-1.87)增加的几率相关。多因素分析还显示,SSc患者出现肺动脉高压、间质性肺疾病、骨质疏松症、Sjögren综合征和高血压等合并症的几率明显更高。结论:SSc的住院患病率超过一般人群患病率,表明对医院护理的需求很高。SSc患者的住院治疗与较差的临床结果和显著较高的医疗支出相关。
{"title":"Epidemiology, outcomes, and expenditures of hospitalized patients with systemic sclerosis: Insights from the U.S. National Inpatient Sample","authors":"Patompong Ungprasert ,&nbsp;Paul T. Kroner","doi":"10.1016/j.jbspin.2025.105985","DOIUrl":"10.1016/j.jbspin.2025.105985","url":null,"abstract":"<div><h3>Objectives</h3><div>The inpatient epidemiology, morbidity, mortality, and healthcare expenditures associated with systemic sclerosis (SSc) remain poorly characterized. This study utilizes a national inpatient database to provide a comprehensive assessment of these parameters.</div></div><div><h3>Methods</h3><div>We identified adult patients with SSc from the 2021 National Inpatient Sample (NIS) using ICD-10-CM codes. The NIS, the largest publicly available all-payer inpatient healthcare database in the U.S., represents data from over 4000 non-federal acute care hospitals. A matched comparator group without SSc was created to serve as comparators. Extracted data included demographics, primary admission diagnoses, length of stay (LOS), in-hospital mortality and morbidity, comorbidities, and healthcare expenditures. Multivariable analyses were adjusted for age, sex, race/ethnicity, Charlson Comorbidity Index, payer type, median income, and hospital characteristics.</div></div><div><h3>Results</h3><div>The inpatient prevalence of SSc was 86.7 per 100,000 admissions. The most common primary diagnoses among SSc hospitalizations were sepsis (22.7%), heart failure with hypertension (14.4%), and COVID-19 (11.5%). The cohort was predominantly female (84.2%) with a mean age of 63.5 years. Compared to non-SSc admissions, SSc hospitalizations were associated with significantly longer LOS (mean difference 0.7 days; 95% CI: 0.5–0.9) and greater healthcare costs, including an adjusted mean increase of $3277 in hospital costs (95% CI: $2051–$4504) and $11,801 in total charges (95% CI: $6485–$17,116). SSc was also associated with increased odds of in-hospital mortality (adjusted OR 1.42; 95% CI: 1.26–1.61), shock (aOR 1.30; 95% CI: 1.17–1.44), systemic inflammatory response syndrome (aOR 1.32; 95% CI: 1.01–1.74), and acute respiratory distress syndrome (aOR 1.45; 95% CI: 1.12–1.87). Multivariate analysis also revealed that patients with SSc had significantly higher odds of several comorbid conditions, including pulmonary hypertension, interstitial lung disease, osteoporosis, Sjögren's syndrome, and hypertension.</div></div><div><h3>Conclusions</h3><div>The inpatient prevalence of SSc exceeds its general population prevalence, indicating a high need for hospital-level care. Hospitalizations among patients with SSc are associated with worse clinical outcomes and significantly greater healthcare expenditures.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105985"},"PeriodicalIF":4.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teleconsultation for rheumatoid arthritis: A selective therapeutic tool in routine care 类风湿性关节炎远程会诊:常规护理中的一种选择性治疗工具。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-30 DOI: 10.1016/j.jbspin.2025.105983
Jérôme Avouac, Olivier Fogel, Anna Molto, Yannick Allanore
{"title":"Teleconsultation for rheumatoid arthritis: A selective therapeutic tool in routine care","authors":"Jérôme Avouac,&nbsp;Olivier Fogel,&nbsp;Anna Molto,&nbsp;Yannick Allanore","doi":"10.1016/j.jbspin.2025.105983","DOIUrl":"10.1016/j.jbspin.2025.105983","url":null,"abstract":"","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105983"},"PeriodicalIF":4.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study 社会和职业因素与普通人群中肌肉骨骼疼痛患病率相关:一项基于人群的队列研究。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-29 DOI: 10.1016/j.jbspin.2025.105984
Florian Bailly , Benjamin Granger , Violaine Foltz , Sofiane Kab , Audrey Petit , Florence Tubach , Bruno Fautrel

Objective

Musculoskeletal pain (MP) is a leading cause of disability worldwide, affecting individual well-being and public health. However, in the literature, the prevalence of MP varies considerably because of methodological inconsistencies, selection biases, and differences in case definitions. This study aimed to estimate the population-based prevalence of MP in France and identify key demographic, socioeconomic, and occupational factors associated with MP.

Methods

This cross-sectional study used baseline data for the CONSTANCES cohort study, a large, population-based epidemiological study with participants representative of the French adult population (18–69 years old). Inverse probability weighting was used to correct for selection bias and to improve the generalizability of prevalence estimates. MP was assessed with the Nordic Musculoskeletal Questionnaire, with significant pain defined as lasting > 30 days in the past 12 months. Multivariate logistic regression models were used to identify factors associated with low back pain, estimating odds ratios (ORs) and 95% confidence intervals (CIs).

Results

Among 193,436 participants, 46.2% reported pain in at least one anatomical site. The most affected areas were the low back (26.6% adjusted prevalence), shoulder (21.4%), neck (19.0%), and knee (19.1%). Odds of low back pain was associated with female sex (OR: 1.39 [95% CI: 1.32–1.47]), older age, obesity, depression (1.71 [1.62–1.80]), and comorbidity burden (1.20 [1.15–1.25]). Odds of low back pain was associated with moderate or high occupational physical activity (OR: 1.33 [1.20–1.50] and 1.69 [1.48–1.93]) but was inversely associated with very active leisure-time physical activity (0.82 [0.70–0.96]). Education level but not household income was a significant socioeconomic factor associated with MP.

Conclusion

MP imposes a substantial burden on the French population, particularly among individuals with physically demanding jobs and low education levels. These findings highlight the paradox of physical activity associated with MP.
目的:肌肉骨骼疼痛(MP)是世界范围内致残的主要原因,影响个人福祉和公共卫生。然而,在文献中,由于方法不一致、选择偏差和病例定义的差异,MP的患病率差异很大。本研究旨在估计法国以人群为基础的MP患病率,并确定与MP相关的关键人口统计学、社会经济和职业因素。方法:本横断面研究使用constance队列研究的基线数据,constance队列研究是一项大型、基于人群的流行病学研究,参与者为具有代表性的法国成年人(18-69岁)。使用逆概率加权来纠正选择偏差并提高患病率估计的泛化性。MP采用北欧肌肉骨骼问卷进行评估,在过去的12个月里,明显的疼痛被定义为持续50 - 30天。使用多变量logistic回归模型确定与腰痛相关的因素,估计优势比(ORs)和95%置信区间(ci)。结果:在193,436名参与者中,46.2%的人报告至少一个解剖部位疼痛。受影响最大的部位是腰背部(26.6%)、肩部(21.4%)、颈部(19.0%)和膝关节(19.1%)。腰痛的发生率与女性(OR 1.39 [95% CI 1.32-1.47])、年龄较大、肥胖、抑郁(1.71[1.62-1.80])和合并症负担(1.20[1.15-1.25])相关。腰痛的发生率与中度或高度职业体力活动相关(or分别为1.33[1.20-1.50]和1.69[1.48-1.93]),但与非常积极的休闲体力活动呈负相关(or为0.82[0.70-0.96])。教育水平是影响MP的重要社会经济因素,而家庭收入不是。结论:MP给法国人带来了巨大的负担,特别是那些体力要求高的工作和低教育水平的人。这些发现强调了与MP相关的体育活动的悖论。
{"title":"Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study","authors":"Florian Bailly ,&nbsp;Benjamin Granger ,&nbsp;Violaine Foltz ,&nbsp;Sofiane Kab ,&nbsp;Audrey Petit ,&nbsp;Florence Tubach ,&nbsp;Bruno Fautrel","doi":"10.1016/j.jbspin.2025.105984","DOIUrl":"10.1016/j.jbspin.2025.105984","url":null,"abstract":"<div><h3>Objective</h3><div>Musculoskeletal pain (MP) is a leading cause of disability worldwide, affecting individual well-being and public health. However, in the literature, the prevalence of MP varies considerably because of methodological inconsistencies, selection biases, and differences in case definitions. This study aimed to estimate the population-based prevalence of MP in France and identify key demographic, socioeconomic, and occupational factors associated with MP.</div></div><div><h3>Methods</h3><div>This cross-sectional study used baseline data for the CONSTANCES cohort study, a large, population-based epidemiological study with participants representative of the French adult population (18–69<!--> <!-->years old). Inverse probability weighting was used to correct for selection bias and to improve the generalizability of prevalence estimates. MP was assessed with the Nordic Musculoskeletal Questionnaire, with significant pain defined as lasting<!--> <!-->&gt;<!--> <!-->30<!--> <!-->days in the past 12<!--> <!-->months. Multivariate logistic regression models were used to identify factors associated with low back pain, estimating odds ratios (ORs) and 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>Among 193,436 participants, 46.2% reported pain in at least one anatomical site. The most affected areas were the low back (26.6% adjusted prevalence), shoulder (21.4%), neck (19.0%), and knee (19.1%). Odds of low back pain was associated with female sex (OR: 1.39 [95% CI: 1.32–1.47]), older age, obesity, depression (1.71 [1.62–1.80]), and comorbidity burden (1.20 [1.15–1.25]). Odds of low back pain was associated with moderate or high occupational physical activity (OR: 1.33 [1.20–1.50] and 1.69 [1.48–1.93]) but was inversely associated with very active leisure-time physical activity (0.82 [0.70–0.96]). Education level but not household income was a significant socioeconomic factor associated with MP.</div></div><div><h3>Conclusion</h3><div>MP imposes a substantial burden on the French population, particularly among individuals with physically demanding jobs and low education levels. These findings highlight the paradox of physical activity associated with MP.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105984"},"PeriodicalIF":4.3,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report 新型CNNM2变异引起低镁血症和早发性焦磷酸钙沉积病1例报告
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-27 DOI: 10.1016/j.jbspin.2025.105982
Caroline Robert , Léa Perrot , Alexia Zelus , Emmanuel Letavernier , Guillaume Courbon , Pierre Lafforgue , Thomas Robert , Nathalie Balandraud
Calcium pyrophosphate deposition (CPPD) disease is a common crystal arthropathy in the elderly, but its early-onset forms are rare. While secondary hypomagnesemia is a recognized contributor to CCPD, inherited renal magnesium-wasting syndromes remain underdiagnosed. Here we performed a whole exome sequencing (ES) in order to detect pathogenic variants in a 58-year-old male patient with early and severe, refractory CPPD disease. We conducted a comprehensive clinical, biochemical, radiological, and genetic evaluation of the patient. ES was performed and filtered for rare, likely pathogenic variants following ACMG/AMP criteria. Cascade genetic testing was performed in family members. Hypomagnesemia with inappropriate renal magnesium loss was found. Radiographs revealed diffuse chondrocalcinosis ES identified a novel heterozygous Cyclin and CBS Domain Divalent Metal Cation Transport Mediator (CNNM2) missense variant (c.319G>C; p.Gly107Arg), absent from population databases and predicted deleterious (REVEL 0.82). This variant affects a highly conserved residue in the extracellular β-barrel domain. Family screening revealed two additional carriers with isolated hypomagnesemia, consistent with autosomal dominant inheritance. CNNM2 encodes a basolateral magnesium transporter in the tubule. This is the first reported case of CPPD linked to a CNNM2 variant through persistent hypomagnesemia. Its variants have been linked to renal hypomagnesemia, neurological comorbidities, but no link to CPPD has been described. This expands the phenotypic spectrum of CNNM2-related disorders and highlights the relevance of genetic testing in CPPD cases with unexplained hypomagnesemia. Building on published functional studies and domain-level protein modeling, we propose a simplified three-tier classification scheme that organizes CNNM2 variants into clinically meaningful categories.
焦磷酸钙沉积(CPPD)病是老年人常见的晶体关节病,但其早发形式是罕见的。虽然继发性低镁血症是CCPD的一个公认因素,但遗传性肾性缺镁综合征仍未得到充分诊断。在这里,我们进行了全基因组测序(ES),以检测一名58岁的早期严重难治性CPPD男性患者的致病变异。我们对患者进行了全面的临床、生化、放射学和遗传学评估。按照ACMG/AMP标准进行ES检查并筛选罕见的、可能的致病变异。对家庭成员进行级联基因检测。发现低镁血症伴不适当的肾镁流失。x线片显示弥漫性软骨钙化症ES鉴定出一种新的杂合CNNM2(细胞周期蛋白和CBS结构域二价金属阳离子运输介质)错义变异(C . 319g >C; p.Gly107Arg),在人群数据库中缺失,预测有害(REVEL 0.82)。这种变异影响细胞外β-桶结构域高度保守的残基。家庭筛查显示另外两名携带者患有孤立性低镁血症,与常染色体显性遗传一致。CNNM2在小管中编码基侧镁转运蛋白。这是第一例报道的CPPD与CNNM2变体通过持续低镁血症相关的病例。它的变异与肾性低镁血症、神经合并症有关,但与CPPD没有联系。这扩大了cnnm2相关疾病的表型谱,并强调了CPPD伴不明原因低镁血症的基因检测的相关性。基于已发表的功能研究和结构域水平的蛋白质建模,我们提出了一个简化的三层分类方案,将CNNM2变异组织成具有临床意义的类别。
{"title":"Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report","authors":"Caroline Robert ,&nbsp;Léa Perrot ,&nbsp;Alexia Zelus ,&nbsp;Emmanuel Letavernier ,&nbsp;Guillaume Courbon ,&nbsp;Pierre Lafforgue ,&nbsp;Thomas Robert ,&nbsp;Nathalie Balandraud","doi":"10.1016/j.jbspin.2025.105982","DOIUrl":"10.1016/j.jbspin.2025.105982","url":null,"abstract":"<div><div>Calcium pyrophosphate deposition (CPPD) disease is a common crystal arthropathy in the elderly, but its early-onset forms are rare. While secondary hypomagnesemia is a recognized contributor to CCPD, inherited renal magnesium-wasting syndromes remain underdiagnosed. Here we performed a whole exome sequencing (ES) in order to detect pathogenic variants in a 58-year-old male patient with early and severe, refractory CPPD disease. We conducted a comprehensive clinical, biochemical, radiological, and genetic evaluation of the patient. ES was performed and filtered for rare, likely pathogenic variants following ACMG/AMP criteria. Cascade genetic testing was performed in family members. Hypomagnesemia with inappropriate renal magnesium loss was found. Radiographs revealed diffuse chondrocalcinosis ES identified a novel heterozygous Cyclin and CBS Domain Divalent Metal Cation Transport Mediator (CNNM2) missense variant (c.319G&gt;C; p.Gly107Arg), absent from population databases and predicted deleterious (REVEL 0.82). This variant affects a highly conserved residue in the extracellular β-barrel domain. Family screening revealed two additional carriers with isolated hypomagnesemia, consistent with autosomal dominant inheritance. CNNM2 encodes a basolateral magnesium transporter in the tubule. This is the first reported case of CPPD linked to a CNNM2 variant through persistent hypomagnesemia. Its variants have been linked to renal hypomagnesemia, neurological comorbidities, but no link to CPPD has been described. This expands the phenotypic spectrum of CNNM2-related disorders and highlights the relevance of genetic testing in CPPD cases with unexplained hypomagnesemia. Building on published functional studies and domain-level protein modeling, we propose a simplified three-tier classification scheme that organizes CNNM2 variants into clinically meaningful categories.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 1","pages":"Article 105982"},"PeriodicalIF":4.3,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current understanding of the challenges in the diagnosis and management of spondyloarthritis in older adults 当前对老年人脊柱炎诊断和治疗挑战的理解。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-27 DOI: 10.1016/j.jbspin.2025.105981
Jacob Corum Williams , Helena Marzo-Ortega
Spondyloarthritis (SpA) encompasses a group of immune-mediated, inflammatory diseases, most notably axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). As the global population ages, so does the population living with these conditions. Age-related immune changes — including chronic low-grade inflammation and the accumulation of senescent T cells — are increasingly recognised as contributors to disease pathophysiology in these individuals. People over the age of 50 often present with a distinct clinical phenotype, including more peripheral arthritis, dactylitis, and psoriasis. A subset may also present with pitting oedema and polymyalgic symptoms, sometimes associated with underlying malignancy. Imaging in older adults can be challenging, as structural and inflammatory changes such as bone marrow oedema and erosions may be seen in asymptomatic individuals without SpA, increasing the risk of misdiagnosis. Age-related comorbidities — including frailty, sarcopenia, falls, fractures, and dementia — occur more frequently in older individuals with SpA, further complicating diagnosis and treatment. Despite this, therapeutic responses appear similar to those in younger populations, particularly with tumour necrosis factor inhibitors (TNFi). Nonetheless, clinicians must be cautious of increased risks of serious infection and heart failure in this age group. Important questions remain about the long-term safety of disease-modifying antirheumatic drugs (DMARDs) in older patients and the efficacy and tolerability of newer biologic or synthetic agents targeting interleukin-17 (IL-17), IL-12/23 and Janus Kinases (JAK) pathways. A better understanding of SpA in older age is critical to delivering effective, individualised care to this growing population.
脊椎关节炎(SpA)包括一组免疫介导的炎症性疾病,最显著的是轴性脊椎关节炎(axSpA)和银屑病关节炎(PsA)。随着全球人口老龄化,生活在这些条件下的人口也在老龄化。与年龄相关的免疫变化——包括慢性低度炎症和衰老T细胞的积累——越来越多地被认为是这些个体疾病病理生理学的贡献者。50岁以上的人通常表现出明显的临床表型,包括更多的外周关节炎、趾炎和牛皮癣。一个亚群也可能出现凹陷性水肿和多肌痛症状,有时与潜在的恶性肿瘤有关。老年人的影像学可能具有挑战性,因为在无SpA的无症状个体中可能看到骨髓水肿和糜烂等结构和炎症变化,增加了误诊的风险。年龄相关的合并症——包括虚弱、肌肉减少症、跌倒、骨折和痴呆——在老年SpA患者中更常见,这进一步使诊断和治疗复杂化。尽管如此,治疗反应似乎与年轻人群相似,特别是使用肿瘤坏死因子抑制剂(TNFi)。尽管如此,临床医生必须警惕这个年龄组严重感染和心力衰竭的风险增加。老年患者使用改善疾病的抗风湿药物(DMARDs)的长期安全性以及针对白细胞介素-17 (IL-17)、IL-12/23和Janus激酶(JAK)途径的新型生物或合成药物的疗效和耐受性仍然存在重要问题。更好地了解老年SpA对于向这一不断增长的人口提供有效的个性化护理至关重要。
{"title":"Current understanding of the challenges in the diagnosis and management of spondyloarthritis in older adults","authors":"Jacob Corum Williams ,&nbsp;Helena Marzo-Ortega","doi":"10.1016/j.jbspin.2025.105981","DOIUrl":"10.1016/j.jbspin.2025.105981","url":null,"abstract":"<div><div>Spondyloarthritis (SpA) encompasses a group of immune-mediated, inflammatory diseases, most notably axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). As the global population ages, so does the population living with these conditions. Age-related immune changes — including chronic low-grade inflammation and the accumulation of senescent T cells — are increasingly recognised as contributors to disease pathophysiology in these individuals. People over the age of 50 often present with a distinct clinical phenotype, including more peripheral arthritis, dactylitis, and psoriasis. A subset may also present with pitting oedema and polymyalgic symptoms, sometimes associated with underlying malignancy. Imaging in older adults can be challenging, as structural and inflammatory changes such as bone marrow oedema and erosions may be seen in asymptomatic individuals without SpA, increasing the risk of misdiagnosis. Age-related comorbidities — including frailty, sarcopenia, falls, fractures, and dementia — occur more frequently in older individuals with SpA, further complicating diagnosis and treatment. Despite this, therapeutic responses appear similar to those in younger populations, particularly with tumour necrosis factor inhibitors (TNFi). Nonetheless, clinicians must be cautious of increased risks of serious infection and heart failure in this age group. Important questions remain about the long-term safety of disease-modifying antirheumatic drugs (DMARDs) in older patients and the efficacy and tolerability of newer biologic or synthetic agents targeting interleukin-17 (IL-17), IL-12/23 and Janus Kinases (JAK) pathways. A better understanding of SpA in older age is critical to delivering effective, individualised care to this growing population.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 1","pages":"Article 105981"},"PeriodicalIF":4.3,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccinating patients with autoimmune diseases 为自身免疫性疾病患者接种疫苗。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-26 DOI: 10.1016/j.jbspin.2025.105978
Ai Li Yeo , Kevin L. Winthrop

Purpose

Vaccine preventable diseases, especially respiratory infections, occur at higher frequency in patients with rheumatic diseases who are immunosuppressed. The focus of this review is to highlight vaccinations that patients with rheumatic diseases should optimally receive, with a focus on efficacy and safety of vaccines.

Main findings

In general, vaccines are effective in reducing the burden of infection. However, due to underlying immunosuppression, their efficacy is most likely reduced compared to the general population. This is even true of the novel vaccines, mRNA and subunit vaccines. Emerging evidence, particularly for withholding methotrexate for 1–2 weeks post vaccination can improve immunogenicity without significantly increasing the risk of disease flare. Administration of live vaccines continue to provide clinicians a challenge especially in the setting of recent measles outbreaks. Assessing underlying degree of immunosuppression and following national guidelines can help clinicians vaccinate these patients safely. If this is not possible, then measles immunoglobulin can be administered.

Principle conclusions

Vaccination is an important part of infection reduction strategies for the rheumatologist to consider during a consultation as the number of vaccines available for infective conditions increases. High dose prednisolone, B cell depleting therapies, and methotrexate have the most evidence for reduced vaccine responses and where feasible, attempts should be made to vaccinate when immunosuppression is thought to be lower.
目的:疫苗可预防的疾病,特别是呼吸道感染,在免疫抑制的风湿病患者中发病率更高。本综述的重点是强调风湿病患者应最佳接种的疫苗,重点是疫苗的有效性和安全性。主要发现:总的来说,疫苗在减少感染负担方面是有效的。然而,由于潜在的免疫抑制,与一般人群相比,他们的疗效很可能降低。这甚至适用于新型疫苗、mRNA和亚基疫苗。新出现的证据,特别是在疫苗接种后1-2周不服用甲氨蝶呤可以改善免疫原性,而不会显著增加疾病爆发的风险。活疫苗的施用继续给临床医生带来挑战,特别是在最近麻疹暴发的背景下。评估潜在的免疫抑制程度并遵循国家指南可以帮助临床医生安全地为这些患者接种疫苗。如果这是不可能的,那么麻疹免疫球蛋白可以给予。主要结论:疫苗接种是风湿病学家在咨询期间考虑的减少感染策略的重要组成部分,因为可用于传染病的疫苗数量增加。大剂量强的松龙、B细胞消耗疗法和甲氨蝶呤在降低疫苗反应方面的证据最多,在可行的情况下,应在认为免疫抑制较低时尝试接种疫苗。
{"title":"Vaccinating patients with autoimmune diseases","authors":"Ai Li Yeo ,&nbsp;Kevin L. Winthrop","doi":"10.1016/j.jbspin.2025.105978","DOIUrl":"10.1016/j.jbspin.2025.105978","url":null,"abstract":"<div><h3>Purpose</h3><div>Vaccine preventable diseases, especially respiratory infections, occur at higher frequency in patients with rheumatic diseases who are immunosuppressed. The focus of this review is to highlight vaccinations that patients with rheumatic diseases should optimally receive, with a focus on efficacy and safety of vaccines.</div></div><div><h3>Main findings</h3><div>In general, vaccines are effective in reducing the burden of infection. However, due to underlying immunosuppression, their efficacy is most likely reduced compared to the general population. This is even true of the novel vaccines, mRNA and subunit vaccines. Emerging evidence, particularly for withholding methotrexate for 1–2 weeks post vaccination can improve immunogenicity without significantly increasing the risk of disease flare. Administration of live vaccines continue to provide clinicians a challenge especially in the setting of recent measles outbreaks. Assessing underlying degree of immunosuppression and following national guidelines can help clinicians vaccinate these patients safely. If this is not possible, then measles immunoglobulin can be administered.</div></div><div><h3>Principle conclusions</h3><div>Vaccination is an important part of infection reduction strategies for the rheumatologist to consider during a consultation as the number of vaccines available for infective conditions increases. High dose prednisolone, B cell depleting therapies, and methotrexate have the most evidence for reduced vaccine responses and where feasible, attempts should be made to vaccinate when immunosuppression is thought to be lower.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105978"},"PeriodicalIF":4.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new biochemical score from synovial fluid for diagnosing septic arthritis 滑膜液生化评分诊断脓毒性关节炎的新方法。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-26 DOI: 10.1016/j.jbspin.2025.105980
Isabelle Sacco , Chayma Saadan , Laura Pina Vegas , Xavier Chevalier , Bérénice Souhail , Raphael Lepeule , Nadia Oubaya , Jean-Philippe Bastard , Soraya Fellahi , Florent Eymard

Objectives

To evaluate the diagnostic performance of synovial fluid (SF) biochemical markers and assess the value of combining their measurements into a composite score for identifying septic arthritis (SA).

Methods

Patients who underwent arthrocentesis with SF biochemical analysis (proteins, glucose, lactate dehydrogenase (LDH), lactate) were included in the initial cohort (IC) (May 2018-May 2021) or the validation cohort (June 2021–March 2023). Using IC data, we compared marker levels in SA vs. non-SA and vs. crystal-related arthritis (C-rA) subgroup. Based on receiver operating characteristic (ROC) curves, we identified two thresholds (one optimizing sensitivity, the other specificity) to assign a score of 0–2 for each biomarker. We developed a composite score by combining the individual scores for discriminative biomarkers and assessed its diagnostic performance.

Results

We included 190 SF (170 patients) in the IC; 36 SF (18.9%) were septic. Glucose level was lower in SA than non-SA and C-rA, but lactate and LDH levels were higher (P < 0.001). The composite score was developed with a 0–6 scale, with the following thresholds: glucose (≤ 7 and ≤ 1.5 mmol/L), lactate (≥ 4.5 and ≥ 7.5 mmol/L), and LDH (≥ 600 and ≥ 1200 UI/L). A composite score ≥ 3 had 100% sensitivity and 73.9% specificity for SA diagnosis in the IC cohort, and a score≥ 5 had 55.5% sensitivity and 97.8% specificity. These findings were consistent in the validation cohort.

Conclusion

A combined score based on SF markers including glucose, LDH, and lactate may be an effective method for rapidly ruling out SA. A multicentric study is warranted to confirm these results.
目的:评价滑膜液(SF)生化指标的诊断价值,并评价其综合评分对脓毒性关节炎(SA)的诊断价值。方法:接受关节穿刺并进行SF生化分析(蛋白质、葡萄糖、乳酸脱氢酶(LDH)、乳酸)的患者被纳入初始队列(IC)(2018年5月- 2021年5月)或验证队列(2021年6月- 2023年3月)。使用IC数据,我们比较了SA与非SA以及与晶体相关关节炎(C-rA)亚组的标志物水平。根据受试者工作特征(ROC)曲线,我们确定了两个阈值(一个优化灵敏度,另一个优化特异性),为每个生物标志物分配0-2分。我们通过结合辨别性生物标志物的个体得分来开发一个综合评分,并评估其诊断性能。结果:我们在IC中纳入190例SF(170例患者);脓毒性SF 36例(18.9%)。SA患者的葡萄糖水平低于非SA患者和C-rA患者,但乳酸和LDH水平高于非SA患者(p结论:基于SF标志物包括葡萄糖、LDH和乳酸的综合评分可能是快速排除SA的有效方法。需要多中心研究来证实这些结果。
{"title":"A new biochemical score from synovial fluid for diagnosing septic arthritis","authors":"Isabelle Sacco ,&nbsp;Chayma Saadan ,&nbsp;Laura Pina Vegas ,&nbsp;Xavier Chevalier ,&nbsp;Bérénice Souhail ,&nbsp;Raphael Lepeule ,&nbsp;Nadia Oubaya ,&nbsp;Jean-Philippe Bastard ,&nbsp;Soraya Fellahi ,&nbsp;Florent Eymard","doi":"10.1016/j.jbspin.2025.105980","DOIUrl":"10.1016/j.jbspin.2025.105980","url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate the diagnostic performance of synovial fluid (SF) biochemical markers and assess the value of combining their measurements into a composite score for identifying septic arthritis (SA).</div></div><div><h3>Methods</h3><div>Patients who underwent arthrocentesis with SF biochemical analysis (proteins, glucose, lactate dehydrogenase (LDH), lactate) were included in the initial cohort (IC) (May 2018-May 2021) or the validation cohort (June 2021–March 2023). Using IC data, we compared marker levels in SA vs. non-SA and vs. crystal-related arthritis (C-rA) subgroup. Based on receiver operating characteristic (ROC) curves, we identified two thresholds (one optimizing sensitivity, the other specificity) to assign a score of 0–2 for each biomarker. We developed a composite score by combining the individual scores for discriminative biomarkers and assessed its diagnostic performance.</div></div><div><h3>Results</h3><div>We included 190 SF (170 patients) in the IC; 36 SF (18.9%) were septic. Glucose level was lower in SA than non-SA and C-rA, but lactate and LDH levels were higher (<em>P</em> <!-->&lt;<!--> <!-->0.001). The composite score was developed with a 0–6 scale, with the following thresholds: glucose (≤<!--> <!-->7 and ≤<!--> <!-->1.5<!--> <!-->mmol/L), lactate (≥<!--> <!-->4.5 and ≥<!--> <!-->7.5<!--> <!-->mmol/L), and LDH (≥<!--> <!-->600 and ≥<!--> <!-->1200 UI/L). A composite score ≥<!--> <!-->3 had 100% sensitivity and 73.9% specificity for SA diagnosis in the IC cohort, and a score≥<!--> <!-->5 had 55.5% sensitivity and 97.8% specificity. These findings were consistent in the validation cohort.</div></div><div><h3>Conclusion</h3><div>A combined score based on SF markers including glucose, LDH, and lactate may be an effective method for rapidly ruling out SA. A multicentric study is warranted to confirm these results.</div></div>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105980"},"PeriodicalIF":4.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axial spondyloarthritis and polymyalgia rheumatica: When differential diagnosis is not that obvious 轴型脊柱炎和风湿性多肌痛:当鉴别诊断不明显时。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-26 DOI: 10.1016/j.jbspin.2025.105977
Margarida Lucas Rocha , Sofia Ramiro , Alexandre Sepriano
{"title":"Axial spondyloarthritis and polymyalgia rheumatica: When differential diagnosis is not that obvious","authors":"Margarida Lucas Rocha ,&nbsp;Sofia Ramiro ,&nbsp;Alexandre Sepriano","doi":"10.1016/j.jbspin.2025.105977","DOIUrl":"10.1016/j.jbspin.2025.105977","url":null,"abstract":"","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"93 2","pages":"Article 105977"},"PeriodicalIF":4.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyomyositis of the obturator internus muscle 闭孔内肌化脓炎。
IF 4.3 3区 医学 Q1 RHEUMATOLOGY Pub Date : 2025-09-26 DOI: 10.1016/j.jbspin.2025.105979
Théo Renaud , Adrien Le Pluart , Paul Arnolfo , Christelle Darrieutort-Laffite
{"title":"Pyomyositis of the obturator internus muscle","authors":"Théo Renaud ,&nbsp;Adrien Le Pluart ,&nbsp;Paul Arnolfo ,&nbsp;Christelle Darrieutort-Laffite","doi":"10.1016/j.jbspin.2025.105979","DOIUrl":"10.1016/j.jbspin.2025.105979","url":null,"abstract":"","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":"92 6","pages":"Article 105979"},"PeriodicalIF":4.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Joint Bone Spine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1